PARP1 and anemia: Consequently, we concluded to a mixed etiology severe anemia, initially hypo regenerative due to prolonged PARP inhibitor toxicity, and secondly complicated with an extravascular hemolysis due to warm autoimmune hemolytic anemia (wAIHA).